Holen Sie sich die Stockscreener-App
4.56
4.00%
-0.19
Handel nachbörslich:
4.65
0.09
+1.97%
Schlusskurs vom Vortag:
$4.75
Offen:
$4.71
24-Stunden-Volumen:
841.06K
Relative Volume:
1.38
Marktkapitalisierung:
$441.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-238.77M
KGV:
-0.1701
EPS:
-26.808
Netto-Cashflow:
$-216.62M
1W Leistung:
-5.20%
1M Leistung:
+13.43%
6M Leistung:
-0.65%
1J Leistung:
-59.68%
1-Tages-Spanne:
$4.385
$4.75
1-Wochen-Bereich:
$4.385
$4.88
52-Wochen-Spanne:
$2.7601
$13.00
Alumis Inc Stock (ALMS) Company Profile
Firmenname
Alumis Inc
Sektor
Branche
Telefon
650-231-6625
Adresse
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
4.56 | 494.31M | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-10 | Fortgesetzt | Guggenheim | Buy |
| 2025-01-30 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-23 | Eingeleitet | Guggenheim | Buy |
| 2024-07-23 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-23 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Alumis Inc Aktie (ALMS) Neueste Nachrichten
Is a relief rally coming for Alumis Inc. holdersQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com
Real time scanner hits for Alumis Inc. explainedJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com
Will Alumis Inc. continue its uptrendQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Will Alumis Inc. stock remain a Wall Street favoriteFed Meeting & Daily Growth Stock Tips - newser.com
Will Alumis Inc. stock benefit from upcoming earnings reportsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
How to manage a losing position in Alumis Inc.Weekly Stock Report & Consistent Profit Trade Alerts - newser.com
Why Alumis Inc. stock is recommended by analystsJuly 2025 Macro Moves & Entry Point Confirmation Signals - newser.com
Will Alumis Inc. stock benefit from sector rotationJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Momentum divergence signals in Alumis Inc. chart2025 Short Interest & Daily Profit Focused Screening - newser.com
Is Alumis Inc. a candidate for recovery playQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Chart based exit strategy for Alumis Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Analyzing drawdowns of Alumis Inc. with statistical toolsJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
Is Alumis Inc. stock positioned for long term growthJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Pattern recognition hints at Alumis Inc. upsideJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Will Alumis Inc. outperform the marketMarket Movers & Free Real-Time Volume Trigger Notifications - newser.com
Tools to assess Alumis Inc.’s risk profileJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment - MSN
Sentiment Watch: Will Alumis Inc. stock outperform value stocksJuly 2025 Opening Moves & Free Technical Confirmation Trade Alerts - Fundação Cultural do Pará
Finanzdaten der Alumis Inc-Aktie (ALMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):